Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: Balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE);Terapia loco-regionale multimodale dell'epatocarcinoma non resecabile con approccio single-step: termoablazione a radiofrequenza durante occlusione temporanea dell'arteria epatica con catetere da PTA (BO-RFA) plus chemioembolizzazione arteriosa transcatetere (TACE)

Radiologia Medica

Volumn 118, Issue 4, 2013, Pages 555-569

  Iezzi, R ^a   Cesario, V ^a   Siciliani, L ^a   Campanale, M ^a   De Gaetano, A M ^a   Siciliano, M ^a   Agnes, S ^a   Giuliante, F ^a   Grieco, A ^a   Pompili, M ^a   Rapaccini, G L ^a   Gasbarrini, A ^a   Bonomo, L ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Chemoembolization; Combined therapy; Hepatocellular carcinoma; Radiofrequency ablation; Treatment algorithm

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; ETHIODIZED OIL; GELATIN SPONGE;

AGED; ALGORITHM; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BALLOON OCCLUSION; CATHETER ABLATION; CHEMOEMBOLIZATION; COMPARATIVE STUDY; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; METHODOLOGY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATIENT SAFETY; PILOT STUDY; TREATMENT OUTCOME;

AGED; ALGORITHMS; ANTIBIOTIC PROPHYLAXIS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BALLOON OCCLUSION; CARBOPLATIN; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; CHEMOEMBOLIZATION, THERAPEUTIC; COMBINED MODALITY THERAPY; ETHIODIZED OIL; FEMALE; GELATIN SPONGE, ABSORBABLE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PATIENT SAFETY; PILOT PROJECTS; TREATMENT OUTCOME;

EID: 84879421635     PISSN: 00338362     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11547-012-0914-7     Document Type: Article

References (30)

1. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74-108 (Pubitemid 40372904)
2. Ikai I, Arii S, Okazaki M et al (2007) Report of the 17th Nationwide Followup Survey of Primary Liver Cancer in Japan. Hepatol Res 37:676-691 (Pubitemid 47054774)
3. Sasaki A, Iwashita Y, Shibata K et al (2006) Improved long-term survival after liver resection for hepatocellular carcinoma in the modern era: retrospective study from HCV-endemic areas. World J Surg 30:1567-1578 (Pubitemid 44421263)
4. Chen XP, Qiu FZ, Wu ZD et al (2006) Long-term outcome of resection of large hepatocellular carcinoma. Br J Surg 93:600-606
5. Taura K, Ikai I, Hatano E et al (2006) Implication of frequent local ablation therapy for intrahepatic recurrence in prolonged survival of patients with hepatocellular carcinoma undergoing hepatic resection: an analysis of 610 patients over 16 years old. Ann Surg 244:265-273 (Pubitemid 44305542)
6. Klintmalm GB (1998) Liver transplantation for hepatocellular carcinoma: a registry report of the impact of tumor characteristics on outcome. Ann Surg 228:479-490 (Pubitemid 30194392)
7. Roayaie S, Frischer JS, Emre SH et al (2002) Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters. Ann Surg 235:533-539 (Pubitemid 34258353)
8. Takayasu K, Arii S, Ikai I et al (2006) Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Gastroenterology 131:461-469 (Pubitemid 44142456)
9. Llovet JM, Burroughs A, Bruix J (2003) Hepatocellular carcinoma. Lancet 362:1907-1917 (Pubitemid 37518510)
10. Livraghi T (2001) Guidelines for treatment of liver cancer. Eur J Ultrasound 13:167-176 (Pubitemid 32463285)
11. Marin-Hargreaves G, Azoulay D, Bismuth H (2003) Hepatocellular carcinoma: surgical indications and results. Crit Rev Oncol Hematol 47:13-27 (Pubitemid 36802322)
12. Alsowmely AM, Hodgson HJ (2002) Non-surgical treatment of hepatocellular carcinoma. Aliment Pharmacol Ther 16:1-15 (Pubitemid 34123859)
13. Durand F, Belghiti J (2002) Liver transplantation for hepatocellular carcinoma. Hepatogastroenterology 49:47-52 (Pubitemid 34289485)
14. Poon RT, Fan ST, Tsang FH, Wong J (2002) Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon's perspective. Ann Surg 235:466-486 (Pubitemid 34258345)
15. Livraghi T, Goldberg SN, Lazzaroni S et al (1999) Small hepatocellular carcinoma: treatment with radiofrequency ablation versus ethanol injection. Radiology 210:655-661 (Pubitemid 29124024)
16. Tateishi R, Shiina S, Teratani T et al (2005) Percutaneous radiofrequency ablation for hepatocellular carcinoma: an analysis of 1000 cases. Cancer 15:1201-1209 (Pubitemid 40328091)
17. Kudo M (2010) Radiofrequency ablation for hepatocellular carcinoma: update review in 2010. Oncology 78:113-124
18. Llovet JM, Real MI, Montana X et al (2002) Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomized controlled trial. Lancet 359:1734-1739 (Pubitemid 34607087)
19. Biolato M, Marrone G, Racco S et al (2010) Transarterial chemoembolization (TACE) for unresectable HCC: a new life begins? Eur Rev Med Pharmacol Sci. 14:356-362
20. Llovet JM, Ricci S, Mazzaferro V et al (2008) Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 359:378-390
21. Liao GS, Yu CY, Shih ML et al (2008) Radiofrequency ablation after transarterial embolization as therapy for patients with unresectable hepatocellular carcinoma. EJSO 34:61-66
22. Yamakado K, Nakatsuka A, Takaki H et al (2008) Early-stage hepatocellular carcinoma: radiofrequency ablation combined with chemoembolization versus hepatectomy. Radiology 247:260-266
23. Cheng BQ, Jia CQ, Liu CT et al (2008) Chemoembolization combined with radiofrequency ablation for patients with hepatocellular carcinoma larger than 3 cm: a randomized controlled trial. JAMA 299:1669-1677 (Pubitemid 351519864)
24. Veltri A, Moretto P, Doriguzzi A et al (2006) Radiofrequency thermal ablation (RFA) after transarterial chemoembolization (TACE) as a combined therapy for unresectable nonearly hepatocellular carcinoma (HCC). Eur Radiol 16:661-669 (Pubitemid 44149378)
25. Takaki H, Yamakado K, Uraki J et al (2009) Radiofrequency ablation combined with chemoembolization for the treatment of hepatocellular carcinomas larger than 5 cm. J Vasc Interv Radiol 20:217-224
26. Bruix J, Sherman M (2005) Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology 42:1208-1236 (Pubitemid 43112690)
27. Goldberg SN, Grassi CJ, Cardella JF et al (2009) Society of Interventional radiology Technology Assessment Committee and the International Working Group on Image-guided Tumor Ablation. Image-guided tumor ablation: standardization of terminology and reporting criteria. J Vasc Interv Radiol 20:377-390
28. Rossi S, Garbagnati F, Leoncini R et al (2000) Percutaneous radio-frequency thermal ablation of nonresectable hepatocellular carcinoma after occlusion of tumor blood supply. Radiology 217:119-126 (Pubitemid 33097587)
29. Yamasaki T, Kurokawa F, Shirahashi H et al (2002) Percutaneous radiofrequency ablation therapy for patients with hepatocellular carcinoma during occlusion of hepatic blood flow. Cancer 95:2353-2360 (Pubitemid 35351142)
30. Ahrar K, Newmann RA, Pang J et al (2004) Dr. Gary J. Becker Young Investigator Award: Relative thermosensitivity of cytotoxic drugs used in transcatheter arterial chemoembolization. J Vasc Interv Radiol 15:901-905 (Pubitemid 39249843)